Atlas Trials

Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients

Clinical trial NCT05343832 · UNKNOWN

Trial details

NCT number
NCT05343832
Sponsor
Genetron Health
Status
UNKNOWN
Study type
OBSERVATIONAL
Liver Cancer
Start date
2021-11-29
Primary completion
2023-03-05
Enrollment
4816

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.